THEUER CHARLES
CIK: 0001631338•PRESIDENT AND CEO
OfficerDirector
Primary company: Tracon Pharmaceuticals, Inc. (TCON)
THEUER CHARLES is a corporate insider (PRESIDENT AND CEO) at Tracon Pharmaceuticals, Inc. (TCON) filing SEC Form 4 transactions. 87 transactions across 3 companies, totaling $749,067 in purchases and $215,592 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Award | 50,000 | $9.42 | $471K | 50,000 | 6/17/2026 Filed: 6/17/2026 | Filing → | |
| Exercise | 9,333 | - | - | 0 | 12/12/2025 Filed: 12/16/2025 | Filing → | |
| Exercise | 9,333 | $1.14 | $11K | 41,684 | 12/12/2025 Filed: 12/16/2025 | Filing → | |
| Award | 22,500 | - | - | 22,500 | 6/17/2025 Filed: 6/20/2025 | Filing → | |
Oncternal Therapeutics, Inc. ONCT | Award | 2,200 | - | - | 2,200 | 6/20/2024 Filed: 6/24/2024 | Filing → |
| Award | 22,500 | - | - | 22,500 | 5/21/2024 Filed: 5/23/2024 | Filing → | |
Tracon Pharmaceuticals, Inc. TCON | Award | 518,300 | - | - | 518,300 | 3/12/2024 Filed: 3/13/2024 | Filing → |
Tracon Pharmaceuticals, Inc. TCON | Award | 3,500 | $0.13 | $467 | 406,417 | 10/20/2023 Filed: 3/13/2024 | Filing → |
Tracon Pharmaceuticals, Inc. TCON | Award | 3,500 | $0.14 | $482 | 402,917 | 4/20/2023 Filed: 3/13/2024 | Filing → |
Oncternal Therapeutics, Inc. ONCT | Award | 25,000 | $0.00 | $0 | 25,000 | 6/28/2023 Filed: 6/30/2023 | Filing → |
4D Molecular Therapeutics, Inc. FMDT | Award | 22,500 | $0.00 | $0 | 22,500 | 5/23/2023 Filed: 5/25/2023 | Filing → |
Tracon Pharmaceuticals, Inc. TCON | Purchase | 47,000 | $0.75 | $35K | 399,417 | 4/27/2023 Filed: 4/28/2023 | Filing → |
Tracon Pharmaceuticals, Inc. TCON | Purchase | 3,999 | $0.66 | $3K | 352,417 | 4/26/2023 Filed: 4/28/2023 | Filing → |
Tracon Pharmaceuticals, Inc. TCON | Purchase | 4,800 | $1.52 | $7K | 344,918 | 3/1/2023 Filed: 3/2/2023 | Filing → |
Tracon Pharmaceuticals, Inc. TCON | Purchase | 200 | $1.52 | $304 | 340,118 | 2/28/2023 Filed: 3/2/2023 | Filing → |
Tracon Pharmaceuticals, Inc. TCON | Award | 332,000 | $0.00 | $0 | 332,000 | 2/1/2023 Filed: 2/3/2023 | Filing → |
Tracon Pharmaceuticals, Inc. TCON | Purchase | 6,800 | $1.62 | $11K | 339,918 | 1/18/2023 Filed: 1/19/2023 | Filing → |
Tracon Pharmaceuticals, Inc. TCON | Purchase | 23,000 | $1.29 | $30K | 333,118 | 12/14/2022 Filed: 12/15/2022 | Filing → |
Tracon Pharmaceuticals, Inc. TCON | Purchase | 13,900 | $1.41 | $20K | 310,118 | 11/18/2022 Filed: 11/22/2022 | Filing → |
Tracon Pharmaceuticals, Inc. TCON | Purchase | 9,200 | $1.52 | $14K | 296,218 | 11/3/2022 Filed: 11/4/2022 | Filing → |
Type
Award
Shares
50,000
Price
$9.42
Value
$471K
Type
Exercise
Shares
9,333
Price
-
Value
-
Type
Exercise
Shares
9,333
Price
$1.14
Value
$11K
Type
Award
Shares
22,500
Price
-
Value
-
Oncternal Therapeutics, Inc.
ONCT
Type
Award
Shares
2,200
Price
-
Value
-
Type
Award
Shares
22,500
Price
-
Value
-
Tracon Pharmaceuticals, Inc.
TCON
Type
Award
Shares
518,300
Price
-
Value
-
Tracon Pharmaceuticals, Inc.
TCON
Type
Award
Shares
3,500
Price
$0.13
Value
$467
Tracon Pharmaceuticals, Inc.
TCON
Type
Award
Shares
3,500
Price
$0.14
Value
$482
Oncternal Therapeutics, Inc.
ONCT
Type
Award
Shares
25,000
Price
$0.00
Value
$0
4D Molecular Therapeutics, Inc.
FMDT
Type
Award
Shares
22,500
Price
$0.00
Value
$0
Tracon Pharmaceuticals, Inc.
TCON
Type
Purchase
Shares
47,000
Price
$0.75
Value
$35K
Tracon Pharmaceuticals, Inc.
TCON
Type
Purchase
Shares
3,999
Price
$0.66
Value
$3K
Tracon Pharmaceuticals, Inc.
TCON
Type
Purchase
Shares
4,800
Price
$1.52
Value
$7K
Tracon Pharmaceuticals, Inc.
TCON
Type
Purchase
Shares
200
Price
$1.52
Value
$304
Tracon Pharmaceuticals, Inc.
TCON
Type
Award
Shares
332,000
Price
$0.00
Value
$0
Tracon Pharmaceuticals, Inc.
TCON
Type
Purchase
Shares
6,800
Price
$1.62
Value
$11K
Tracon Pharmaceuticals, Inc.
TCON
Type
Purchase
Shares
23,000
Price
$1.29
Value
$30K
Tracon Pharmaceuticals, Inc.
TCON
Type
Purchase
Shares
13,900
Price
$1.41
Value
$20K
Tracon Pharmaceuticals, Inc.
TCON
Type
Purchase
Shares
9,200
Price
$1.52
Value
$14K
AI Agent
Try asking...